Overview

A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants

Status:
RECRUITING

Trial end date:
2025-10-29

Target enrollment:

Participant gender:

Summary

This study is conducted to assess the effect of itraconazole, rifampin, and acid-reducing agents on INCB161734 pharmacokinetics when administered orally in healthy participants.

Phase:

PHASE1

Details

Lead Sponsor:

Incyte Corporation

Treatments:

Esomeprazole
Famotidine
Itraconazole
Rifampin